Pink Sheet Podcast: Coronavirus Oversight Hearings Begin, Rick Bright On Capitol Hill, BIO Names J&J Exec As New CEO
Pink Sheet reporter and editor discuss virtual appearance by US FDA Commissioner Stephen Hahn and others on Capitol Hill, GOP right-to-try questions for former BARDA Director Rick Bright, and new BIO CEO Michelle McMurry-Heath.
You may also be interested in...
ACIP defers vote on who should be inoculated first until it has data on a specific product, but vaccine acceptance among different groups could be weighed as factor in setting distribution priorities, committee members suggest.
The possibility, which seems driven by the culture of the times, may be legally possible, but experts raised many practical concerns.
Trial diversity is among the issues that stakeholders worry could hinder vaccine uptake.